The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
Open accessAbstract
The European Society for Medical Oncology (ESMO) consensus conference on testicular cancer was held on 3-5 November 2016 in Paris, France. The conference included a multidisciplinary panel of 36 leading experts in the diagnosis and treatment of testicular cancer (34 panel members attended the conference; an additional two panel members [CB and K-PD] participated in all preparatory work and subsequent manuscript development). The aim of the conference was to develop detailed recommendations on topics relating to testicular cancer that are not covered in detail in the current ESMO Clinical Practice Guidelines (CPGs) and where the available level of evidence is insufficient. The main topics identified for discussion related to: (1) diagnostic work-up and patient assessment; (2) stage I disease; (3) stage II-III disease; (4) post-chemotherapy surgery, salvage chemotherapy, salvage and desperation surgery and special topics; and (5) survivorship and follow-up schemes. The experts addressed questions relating to one of the five topics within five working groups. Relevant scientific literature was reviewed in advance. Recommendations were developed by the working groups and then presented to the entire panel. A consensus vote was obtained following whole-panel discussions, and the consensus recommendations were then further developed in post-meeting discussions in written form. This manuscript presents the results of the expert panel discussions, including the consensus recommendations and a summary of evidence supporting each recommendation. All participants approved the final manuscript.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Computed Tomography — An Increasing Source of Radiation Exposure
Brenner, D. J., & Hall, E. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra072149 · Cited by 8,748
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Moch, H., Cubilla, A. L., Humphrey, P. A., Reuter, V. E., & Ulbright, T. M. (2016) · European Urology · doi:10.1016/j.eururo.2016.02.029 · Cited by 3,086
(1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.594 · Cited by 1,929
TNM: CLASSIFICATION OF MALIGNANT TUMOURS
(1969) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1969.tb116971.x · Cited by 1,382
Williams, S. D., Birch, R., Einhorn, L. H., Irwin, L., Greco, F. A., & Loehrer, P. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162302 · Cited by 1,170
Mead, G. M., Stenning, S. P., Cook, P. A., Fosså, S. D., Horwich, A., Kaye, S. B., Oliver, R. T. D., deMulder, P., deWit, R., Stoter, G., et al. (1997) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 1,033
Self-citationSecond Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
Travis, L. B., Fosså, S. D., Schonfeld, S. J., McMaster, M. L., Lynch, C. F., Storm, H., Hall, P., Holowaty, E., Andersen, A., Pukkala, E., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji278 · Cited by 823
Self-citationSKAKKEBÆK, N. E., BERTHELSEN, J. G., GIWERCMAN, A., & MÜLLER, J. (1987) · International Journal of Andrology · doi:10.1111/j.1365-2605.1987.tb00161.x · Cited by 741
Guidelines on Testicular Cancer: 2015 Update
Albers, P., Albrecht, W., Algaba, F., Bokemeyer, C., Cohn-Cedermark, G., Fizazi, K., Horwich, A., Laguna, M. P., Nicolai, N., & Oldenburg, J. (2015) · European Urology · doi:10.1016/j.eururo.2015.07.044 · Cited by 670
Self-citationDykewicz, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321805 · Cited by 636
Prognostic Factors for Relapse in Stage I Seminoma Managed by Surveillance: A Pooled Analysis
Warde, P., Specht, L., Horwich, A., Oliver, T., Panzarella, T., Gospodarowicz, M., & von der Maase, H. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.01.038 · Cited by 568
Self-citationCardiovascular Disease as a Long-Term Complication of Treatment for Testicular Cancer
Huddart, R. A., Norman, A., Shahidi, M., Horwich, A., Coward, D., Nicholls, J., & Dearnaley, D. P. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.173 · Cited by 547
Self-citationHigh-Dose Chemotherapy and Stem-Cell Rescue for Metastatic Germ-Cell Tumors
Einhorn, L. H., Williams, S. D., Chamness, A., Brames, M. J., Perkins, S. M., & Abonour, R. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067749 · Cited by 496
Kondagunta, G. V., Bacik, J., Donadio, A., Bajorin, D., Marion, S., Sheinfeld, J., Bosl, G. J., & Motzer, R. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.19.638 · Cited by 418
Haugnes, H. S., Wethal, T., Aass, N., Dahl, O., Klepp, O., Langberg, C. W., Wilsgaard, T., Bremnes, R. M., & Fosså, S. D. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.9362 · Cited by 404
Self-citationRajpert-De Meyts, E., McGlynn, K. A., Okamoto, K., Jewett, M. A. S., & Bokemeyer, C. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00991-5 · Cited by 398
Self-citationMotzer, R. J., Nichols, C. J., Margolin, K. A., Bacik, J., Richardson, P. G., Vogelzang, N. J., Bajorin, D. F., Lara, P. N., Einhorn, L., Mazumdar, M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.4528 · Cited by 353
Albers, P., Siener, R., Krege, S., Schmelz, H.-U., Dieckmann, K.-P., Heidenreich, A., Kwasny, P., Pechoel, M., Lehmann, J., Kliesch, S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.0899 · Cited by 337
Self-citationThe International Prognostic Factors Study Group (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.8128 · Cited by 322
Beyer, J., Albers, P., Altena, R., Aparicio, J., Bokemeyer, C., Busch, J., Cathomas, R., Cavallin-Stahl, E., Clarke, N. W., Claßen, J., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds579 · Cited by 320
Self-citationOliver, R. T. D., Mead, G. M., Rustin, G. J. S., Joffe, J., Aass, N., Coleman, R. L., Gabe, R., Pollock, P., & Stenning, S. P. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.4655 · Cited by 314
Jones, W. G., Fosså, S. D., Mead, G. M., Roberts, J. T., Sokal, M., Horwich, A., & Stenning, S. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.003 · Cited by 307
Self-citationFertility, gonadal and sexual function in survivors of testicular cancer
Huddart, R. A., Norman, A., Moynihan, C., Horwich, A., Parker, C., Nicholls, E., & Dearnaley, D. P. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602677 · Cited by 295
Self-citationOldenburg, J., Fosså, S. D., Nuver, J., Heidenreich, A., Schmoll, H.-J., Bokemeyer, C., Horwich, A., Beyer, J., & Kataja, V. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt304 · Cited by 282
Self-citationLoehrer, P. J., Lauer, R., Roth, B. J., Williams, S. D., Kalasinski, L. A., & Einhorn, L. H. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-7-540 · Cited by 276
Lorch, A., Bascoul-Mollevi, C., Kramar, A., Einhorn, L., Necchi, A., Massard, C., De Giorgi, U., Fléchon, A., Margolin, K., Lotz, J.-P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.6678 · Cited by 273
Self-citationPaternity Following Treatment for Testicular Cancer
Brydøy, M., Fosså, S. D., Klepp, O., Bremnes, R. M., Wist, E. A., Wentzel-Larsen, T., & Dahl, O. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji339 · Cited by 272
Self-citationTandstad, T., Dahl, O., Cohn-Cedermark, G., Cavallin-Stahl, E., Stierner, U., Solberg, A., Langberg, C., Bremnes, R. M., Laurell, A., Wijkstrøm, H., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.8953 · Cited by 262
Self-citationMotzer, R. J., Sheinfeld, J., Mazumdar, M., Bains, M., Mariani, T., Bacik, J., Bajorin, D., & Bosl, G. J. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.12.2413 · Cited by 253
Collette, L. (1999) · Journal of the National Cancer Institute · doi:10.1093/jnci/91.10.839 · Cited by 246
Daugaard, G., Gundgaard, M. G., Mortensen, M. S., Agerbæk, M., Holm, N. V., Rørth, M., von der Maase, H., Christensen, I. J., & Lauritsen, J. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5831 · Cited by 238
Self-citationChan, R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.8978 · Cited by 230
Fizazi, K., Pagliaro, L., Laplanche, A., Fléchon, A., Mardiak, J., Geoffrois, L., Kerbrat, P., Chevreau, C., Delva, R., Rolland, F., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70490-5 · Cited by 207
Self-citationA Nationwide Cohort Study of Stage I Seminoma Patients Followed on a Surveillance Program
Mortensen, M. S., Lauritsen, J., Gundgaard, M. G., Agerbæk, M., Holm, N. V., Christensen, I. J., von der Maase, H., & Daugaard, G. (2014) · European Urology · doi:10.1016/j.eururo.2014.07.001 · Cited by 204
Self-citationSurgical salvage of chemorefractory germ cell tumors.
Murphy, B. R., Breeden, E. S., Donohue, J. P., Messemer, J., Walsh, W., Roth, B. J., & Einhorn, L. H. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.2.324 · Cited by 198
Stephenson, A. J., Bosl, G. J., Motzer, R. J., Kattan, M. W., Stasi, J., Bajorin, D. F., & Sheinfeld, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.132 · Cited by 198
Carcinoma in situ testis, the progenitor of testicular germ cell tumours: a clinical review
Hoei-Hansen, C. E., Rajpert-De Meyts, E., Daugaard, G., & Skakkebaek, N. E. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi175 · Cited by 198
Self-citationGenetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors
Bagrodia, A., Lee, B. H., Lee, W., Cha, E. K., Sfakianos, J. P., Iyer, G., Pietzak, E. J., Gao, S. P., Zabor, E. C., Ostrovnaya, I., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.7798 · Cited by 198
Hematologic Disorders Associated With Primary Mediastinal Nonseminomatous Germ Cell Tumors
Hartmann, J. T., Nichols, C. R., Droz, J.-P., Horwich, A., Gerl, A., Fossa, S. D., Beyer, J., Pont, J., Fizazi, K., Einhorn, L., et al. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.1.54 · Cited by 189
Self-citationMotzer, R. J., Bajorin, D. F., Schwartz, L. H., Hutter, H. S., Bosl, G. J., Scher, H. I., Lyn, P., & Fischer, P. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.11.2277 · Cited by 176
Fertility after testicular cancer treatments
Huyghe, É., Matsuda, T., Daudin, M., et al. (2004) · Cancer · doi:10.1002/cncr.11950 · Cited by 167
Berney, D. M., Looijenga, L. H. J., Idrees, M., Oosterhuis, J. W., Rajpert‐De Meyts, E., Ulbright, T. M., & Skakkebaek, N. E. (2016) · Histopathology · doi:10.1111/his.12958 · Cited by 167
Self-citationDaugaard, G., Skoneczna, I., Aass, N., de Wit, R., Santis, M. D., Dumez, H., Marreaud, S. I., Collette, L., Lluch, J. R. G., Bokemeyer, C., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq575 · Cited by 163
Self-citationSEMEN QUALITY AND REPRODUCTIVE HORMONES BEFORE AND AFTER ORCHIECTOMY IN MEN WITH TESTICULAR CANCER
PETERSEN, P. M., SKAKKEBAEK, N. E., RORTH, M., & GIWERCMAN, A. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)61781-6 · Cited by 163
Bachner, M., Loriot, Y., Gross‐Goupil, M., Zucali, P. A., Horwich, A., Germa-Lluch, J. R., Kollmannsberger, C., Stoiber, F., Fléchon, A., Oechsle, K., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr052 · Cited by 159
Self-citationMetastatic nonseminomatous germ cell tumors of the testis
Hendry, W. F., Norman, A. R., Dearnaley, D. P., Fisher, C., Nicholls, J., Huddart, R. A., & Horwich, A. (2002) · Cancer · doi:10.1002/cncr.10440 · Cited by 159
Self-citationEvaluation of a prognostic model for risk of relapse in stage I seminoma surveillance
Chung, P. W. M., Daugaard, G., Tyldesley, S. K., Atenafu, E. G., Panzarella, T., Kollmannsberger, C., & Warde, P. R. (2014) · Cancer Medicine · doi:10.1002/cam4.324 · Cited by 153
Self-citationHinton, S., Catalano, P. J., Einhorn, L. H., Loehrer, P. J., Kuzel, T. M., Vaughn, D. J., & Wilding, G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.158 · Cited by 146
FDG PET for detection and therapy control of metastatic germ cell tumor.
Cremerius, U., Effert, P. J., Adam, G., Sabri, O., Zimmy, M., Wagenknecht, G., Jakse, G., & Buell, U. (1998) · PubMed · Cited by 141
Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer
Bokemeyer, C., Beyer, J., Metzner, B., Rüther, U., Harstrick, A., Weißbach, L., Köhrmann, U., Verbeek, W., & Schmoll, H. (1996) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a010473 · Cited by 138
Self-citationHuang, D. Y., & Sidhu, P. S. (2012) · British Journal of Radiology · doi:10.1259/bjr/30029741 · Cited by 138
Gemcitabine in Patients With Relapsed or Cisplatin-Refractory Testicular Cancer
Bokemeyer, C., Gerl, A., Schöffski, P., Harstrick, A., Niederle, N., Beyer, J., Casper, J., Schmoll, H., & Kanz, L. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.512 · Cited by 138
Self-citationRuf, C. G., Hendrik Isbarn, A., Wagner, W. P., Fisch, M. M., Matthies, C., & Dieckmann, K. (2013) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.12.002 · Cited by 135
Self-citationPhase II Trial of Gemcitabine in Refractory Germ Cell Tumors
Einhorn, L. H., Stender, M., & Williams, S. D. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.509 · Cited by 134
Rives, N., Perdrix, A., Hennebicq, S., Saias‐Magnan, J., Melin, M. C., Berthaut, I., Barthélémy, C., Daudin, M., Szerman, E., Bresson, J.-L., et al. (2012) · Journal of Andrology · doi:10.2164/jandrol.112.016592 · Cited by 134
Party, O. B. O. T. M. T. T. W., Mead, G. M., Cullen, M. H., Huddart, R. A., Harper, P., Rustin, G. J. S., Cook, P., Stenning, S. P., & Mason, M. D. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602682 · Cited by 132
Self-citationSALVAGE SURGERY OF CHEMOREFRACTORY GERM CELL TUMORS WITH ELEVATED TUMOR MARKERS
Albers, P., GANZ, A., HANNIG, E., Miersch, W. D. E., & MÜLLER, S. C. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)67365-x · Cited by 119
Sturgeon, J. F. G., Moore, M. J., Kakiashvili, D., Durán, I., Anson‐Cartwright, L., Berthold, D., Warde, P. R., Gospodarowicz, M. K., Alison, R. E., Liu, J., et al. (2010) · European Urology · doi:10.1016/j.eururo.2010.12.010 · Cited by 119
Self-citationPhase II study of daily oral etoposide in refractory germ cell tumors.
Miller, J. C., & Einhorn, L. H. (1990) · PubMed · Cited by 112
Late recurrences of germ cell malignancies: a population-based experience over three decades
Oldenburg, J., Alfsen, G. C., Wæhre, H., & Fosså, S. D. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603014 · Cited by 112
Self-citationKollmannsberger, C., Rick, O., Derigs, H. G., Schleucher, N., Schöffski, P., Beyer, J., Schoch, R., Sayer, H. G., Gerl, A., Kuczyk, M. A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.050 · Cited by 107
Self-citationPectasides, D., Pectasides, M., Farmakis, D. T., Aravantinos, G., Nikolaou, M., Koumpou, M., Gaglia, A., Kostopoulou, V., Mylonakis, N., & Skarlos, D.-V. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh103 · Cited by 104
Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma
Horwich, A., Fosså, S. D., Huddart, R. A., Dearnaley, D. P., Stenning, S. P., Aresu, M., Bliss, J. M., & Hall, E. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.551 · Cited by 103
Self-citationFeldman, D. R., Lorch, A., Kramar, A., Albany, C., Einhorn, L. H., Giannatempo, P., Necchi, A., Fléchon, A., Boyle, H. J., Chung, P. W. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.7000 · Cited by 101
Self-citationGiannatempo, P., Pond, G. R., Sonpavde, G., Albany, C., Loriot, Y., Sweeney, C. J., Salvioni, R., Colecchia, M., Nicolai, N., Raggi, D., et al. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.12.082 · Cited by 94
Self-citationOechsle, K., Kollmannsberger, C., Honecker, F. U., Mayer, F., Waller, C. F., Hartmann, J. T., Boehlke, I., & Bokemeyer, C. (2011) · European Urology · doi:10.1016/j.eururo.2011.06.019 · Cited by 92
Self-citationBrydøy, M., Fosså, S. D., Klepp, O., Bremnes, R. M., Wist, E. A., Wentzel‐Larsen, T., & Dahl, O. (2010) · European Urology · doi:10.1016/j.eururo.2010.03.041 · Cited by 92
Self-citationOutcomes in stage I testicular seminoma: A population‐based study of 9193 patients
Beard, C. J., Travis, L. B., Chen, M., Arvold, N. D., Nguyen, P. L., Martin, N. E., Kuban, D. A., Ng, A. K., & Hoffman, K. E. (2013) · Cancer · doi:10.1002/cncr.28086 · Cited by 85
De Giorgi, U., Rosti, G., Aieta, M., Testore, F., Burattini, L., Fornarini, G., Naglieri, E., Lo Re, G., Zumaglini, F., & Marangolo, M. (2006) · European Urology · doi:10.1016/j.eururo.2006.05.011 · Cited by 81
Congenital malformations and testicular germ cell tumors
Trabert, B. L., Zugna, D., Richiardi, L., McGlynn, K. A., & Akre, O. (2013) · International Journal of Cancer · doi:10.1002/ijc.28207 · Cited by 79
Population Landscape of Familial Cancer
Frank, C., Fallah, M., Sundquist, J., Hemminki, A., & Hemminki, K. (2015) · Scientific Reports · doi:10.1038/srep12891 · Cited by 79
Self-citationSchnack, T. H., Poulsen, G., Myrup, C., Wohlfahrt, J., & Melbye, M. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp457 · Cited by 79
Lorch, A., Neubauer, A., Hackenthal, M., Dieing, A., Hartmann, J. T., Rick, O., Bokemeyer, C., & Beyer, J. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp366 · Cited by 78
Self-citationKier, M. G. G., Lauritsen, J., Mortensen, M. S., Bandak, M., Andersen, K. K., Hansen, M. K., Agerbæk, M., Holm, N. V., Dalton, S. O., Johansen, C., et al. (2016) · European Urology · doi:10.1016/j.eururo.2016.09.015 · Cited by 78
Self-citationThe Role of Retroperitoneal Lymphadenectomy in Mature Teratoma of the Testis
Heidenreich, A., Moul, J. W., McLeod, D. G., Mostofi, F. K., & Engelmann, U. H. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)65313-8 · Cited by 73
Self-citationLitchfield, K., Thomsen, H., Mitchell, J. S., Sundquist, J., Houlston, R. S., Hemminki, K., & Turnbull, C. (2015) · Scientific Reports · doi:10.1038/srep13889 · Cited by 72
Self-citationRational Selection of Patients for Antibacterial Prophylaxis After Chemotherapy
Cullen, M. H., Billingham, L. J., Gaunt, C. H., & Steven, N. M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.7395 · Cited by 62
Litchfield, K., SHIPLEY, J. M., & Turnbull, C. (2015) · Andrology · doi:10.1111/andr.304 · Cited by 58
Second cancers after testicular cancer diagnosed after 1980 in Sweden
Hemminki, K., Liu, H., & Sundquist, J. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp562 · Cited by 55
Self-citationA phase II trial of paclitaxel in refractory germ cell tumors
Sandler, A., Cristou, A., Fox, S., Williams, S. D., Nichols, C. R., Turns, M., & Roth, B. J. (1998) · Cancer · Cited by 54
Adra, N., Althouse, S. K., Liu, H., Brames, M. J., Hanna, N. H., Einhorn, L. H., & Albany, C. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw045 · Cited by 54
Dieckmann, K., Linke, J., Pichlmeier, U., Kulejewski, M., & Loy, V. (2007) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06686.x · Cited by 51
Self-citationEffect of Radiotherapy Volume and Dose on Secondary Cancer Risk in Stage I Testicular Seminoma
Zwahlen, D. R., Martin, J. M., Millar, J. L., & Schneider, U. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.10.007 · Cited by 49
International testicular cancer incidence trends: generational transitions in 38 countries 1900–1990
Znaor, A., Lortet‐Tieulent, J., Laversanne, M., Jemal, A., & Bray, F. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0486-z · Cited by 46
Late Relapses in Stage I Testicular Cancer Patients on Surveillance
Mortensen, M. S., Lauritsen, J., Kier, M. G. G., Bandak, M., Appelt, A. L., Agerbæk, M., Holm, N. V., Kempel, M. M., von der Maase, H., & Daugaard, G. (2016) · European Urology · doi:10.1016/j.eururo.2016.03.016 · Cited by 46
Self-citationIdentification of four new susceptibility loci for testicular germ cell tumour
Litchfield, K., Holroyd, A., Lloyd, A., Broderick, P., Nsengimana, J., Eeles, R. A., Easton, D. F., Dudakia, D., Bishop, D. T., Reid, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms9690 · Cited by 44
Self-citationThe value of central histopathological review of testicular tumours before treatment
Lee, Mead, & Theaker (1999) · British Journal of Urology · doi:10.1046/j.1464-410x.1999.00048.x · Cited by 43
Ravi, P. K., Gray, K. P., O’Donnell, E., & Sweeney, C. J. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt425 · Cited by 42
Ko, J. J., Bernard, B. D., Tran, B., Li, H., Asif, T., Stukalin, I., Lee, M., Day, D., Alimohamed, N. S., Sweeney, C. J., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.7909 · Cited by 41
Feldman, D. R., Voss, M. H., Jacobsen, E. P., Jia, X., Suarez, J. A., Turkula, S., Sheinfeld, J., Bosl, G. J., Motzer, R. J., & Patil, S. (2013) · Cancer · doi:10.1002/cncr.28025 · Cited by 37
Fertility among testicular cancer survivors: a case-control study in the U.S.
Kim, C., McGlynn, K. A., McCorkle, R. C., Zheng, T., Erickson, R. L., Niebuhr, D. W., Ma, S., Zhang, Y., Dai, L., Dai, L., et al. (2010) · Journal of Cancer Survivorship · doi:10.1007/s11764-010-0134-x · Cited by 32
Necchi, A., Pond, G. R., Nicolai, N., Giannatempo, P., Raggi, D., Adra, N., Hanna, N. H., Salvioni, R., Einhorn, L. H., & Albany, C. (2016) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2016.07.022 · Cited by 28
Self-citationPaclitaxel in extensively pretreated nonseminomatous germ cell tumors
Nazario, A., Amato, R. J., Hutchinson, L., Bui, C., Ellerhorst, J. A., & Logothetis, C. J. (1995) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/1078-1439(95)00064-x · Cited by 25
Tandstad, T., Ståhl, O., Håkansson, U., Wahlqvist, R., Klepp, O., Cavallin-Ståhl, E. K., & Cohn-Cedermark, G. E. (2015) · Scandinavian Journal of Urology · doi:10.3109/21681805.2015.1059360 · Cited by 23
Self-citationLoriot, Y., Pagliaro, L. C., Fléchon, A., Mardiak, J., Geoffrois, L., Kerbrat, P., Chevreau, C., Delva, R., Rolland, F., Théodore, C., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.09.029 · Cited by 23
Self-citation
Cited by
Human germ cell tumours from a developmental perspective
Oosterhuis, J. W., & Looijenga, L. H. J. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0178-9 · Cited by 328
Lobo, J., Constâncio, V., Leite-Silva, P., Guimarães, R., Cantante, M., Braga, I., Maurício, J., Looijenga, L. H. J., Henrique, R., & Jerónimo, C. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01048-y · Cited by 28
Pęksa, R., Kunc, M., Popęda, M., Piątek, M., Bieńkowski, M., Żok, J., Starzyńska, A., Perdyan, A., Sowa, M., Duchnowska, R., et al. (2021) · Cancers · doi:10.3390/cancers13081750 · Cited by 16
Metadata
- Authors
- Honecker, F., Aparicio, J., Berney, D., Beyer, J., Bokemeyer, C., Cathomas, R., Clarke, N., Cohn-Cedermark, G., Daugaard, G., Dieckmann, K.-P., Fizazi, K., Fosså, S., Germa-Lluch, J. R., Giannatempo, P., Gietema, J. A., Gillessen, S., Haugnes, H. S., Heidenreich, A., Hemminki, K., Huddart, R., Jewett, M. A. S., Joly, F., Lauritsen, J., Lorch, A., Necchi, A., Nicolai, N., Oing, C., Oldenburg, J., Ondruš, D., Papachristofilou, A., Powles, T., Sohaib, A., Ståhl, O., Tandstad, T., Toner, G., & Horwich, A.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 29
- Issue
- 8
- Pages
- 1658-1686
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2886615577
- Cited by
- 326
- References
- 99
- FWCI
- 37.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.